Clinical Trials Browser

Phase 3 × Graft vs Host Disease × Cytarabine × Clear all

NCT02461121 2015-06-04

HLA-mismatched MST vs HLA-matched NST for AML in Intermediate-risk

Phase 3 Completed

Other hematologic neoplasm

Graft vs Host Disease, Leukemia, Myeloid, Acute